Cancer Biomarkers Market, by Biomarker Type, by Cancer Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Cancer biomarkers offers great opportunity in improving management of cancer patients by enhancing the efficiency of detection and efficacy of the treatment. Biomarkers of cancer includes various biochemical components such as proteins, sugars, lipids, nucleic acids, small metabolites, cytogenetic and cytokinetic parameters, and whole tumor cells, which are found in body fluid. Molecular alterations used for cancer diagnosis involves application of DNA, RNA, microRNAs, and proteins.

Biomarker testing is a way to look for genes, proteins, and other substances (called biomarkers or tumor markers) that can provide information about cancer. Each person's cancer has a unique pattern of biomarkers. Some biomarkers affect how certain cancer treatments work. Biomarker testing may help the doctor choose a cancer treatment for you. Biomarker testing for cancer treatment may also be called: tumor testing, tumor genetic testing, genomic testing or genomic profiling, molecular testing or molecular profiling, somatic testing, and tumor subtyping. Biomarker testing is different from genetic testing that is used to find out if someone has inherited mutations that make them more likely to get cancer. Inherited mutations are those you are born with. They are passed on to an individual by parents.

Market Dynamics

Increasing research and development activities in the field of cancer biomarker to develop and identify potential cancer biomarkers for early diagnosis of cancer, is expected to drive growth of the global cancer biomarkers market, in the near future. For instance, in March 2018, a team of researchers from University of Massachusetts and Clarkson University discovered various protein such as human chorionic gonadotropin (hCG), lipoproteins, α1-chymotrypsin and α1-antitrypsin from breast milk, which can act as a potential cancer biomarker in detection of breast cancer.

Key features of the study:

This report provides an in-depth analysis of the global cancer biomarkers market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include bioMerieux, Inc., INOVIQ, Bio-Rad Laboratories, Inc., Abbott, Becton, Dickinson and Company, Merck KgaA, QIAGEN, Thermo Fisher Scientific Inc., CENTOGENE N.V., PerkinElmer Inc., and Siemens Healthcare Private Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biomarkers market

Detailed Segmentation:

Global Cancer Biomarkers Market, By Biomarker Type:
- Protein Biomarkers
- Genetic Biomarkers
- Other Cancer Biomarkers
Global Cancer Biomarkers Market, By Cancer Type:
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Kidney Cancer
- Liver Cancer
- Other Cancers
Global Cancer Biomarkers Market, By End User:
- Hospitals
- Academic and Cancer Research Institutes
- Ambulatory Surgical Centers
- Cancer Diagnostic Laboratories
Global Cancer Biomarkers Market, By Region:
- North America
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- bioMerieux, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- INOVIQ
- Bio-Rad Laboratories, Inc.
- Abbott
- Becton, Dickinson and Company
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific Inc.
- CENTOGENE N.V.
- PerkinElmer Inc.
- Siemens Healthcare Private Limited

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI175

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Biomarker Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis

4. Global Cancer Biomarkers Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global Cancer Biomarkers Market, By Biomarker Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Protein Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Genetic Biomarkers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Other Cancer Biomarkers

6. Global Cancer Biomarkers Market, By Cancer Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Kidney Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Other Cancers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Cancer Biomarkers Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Academic and Cancer Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Cancer Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Cancer Biomarkers Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

bioMerieux, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
INOVIQ
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CENTOGENE N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

Cancer Biomarkers Market, by Biomarker Type, by Cancer Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030